The therapeutic effect of most medications may be slow to manifest and studies in rheumatic diseases have so far failed to confirm a useful association between concentrations and disease control or drug toxicity. PubMed, Rheumatology, 2013 Nov 5. (Also see: Rheumatic Diseases)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.